Back to News
Market Impact: 0.45

ACN Quantitative Stock Analysis

ACNNDAQ
Company FundamentalsAnalyst InsightsTechnology & Innovation
ACN Quantitative Stock Analysis

According to Validea's guru fundamental report, Accenture PLC (ACN) receives an 86% rating based on their Patient Investor model, which is based on Warren Buffett's published investment strategy. The strategy favors firms with predictable profitability, low debt, and reasonable valuations; ACN passes all of the strategy's key tests including earnings predictability, debt service, return on equity, return on total capital and free cash flow, indicating strong interest from this value-oriented investment approach.

Analysis

Accenture PLC (ACN), a large-cap growth stock within the Computer Services industry, has achieved an 86% rating according to Validea's Patient Investor model, which is based on Warren Buffett's published investment strategy. This model identifies companies with sustained, predictable profitability, minimal debt, and sensible valuations. An 86% score indicates significant alignment with the strategy's criteria, nearing the 90% threshold for strong interest. Notably, ACN passed all nine fundamental tests evaluated by this model: earnings predictability, debt service, return on equity, return on total capital, free cash flow, use of retained earnings, share repurchase, initial rate of return, and expected return. This comprehensive positive assessment is supported by an overall strongly positive sentiment (0.7) for the report and a specific high sentiment score (0.85) for ACN, reflecting an optimistic view of its fundamental strength through this value-investing framework.

AllMind AI Terminal

AI-powered research, real-time alerts, and portfolio analytics for institutional investors.

Request a Demo

Market Sentiment

Overall Sentiment

strongly positive

Sentiment Score

0.70

Ticker Sentiment

ACN0.85
NDAQ0.00

Key Decisions for Investors

  • Investors employing a long-term, value-focused investment approach, similar to that of Warren Buffett, may find Accenture's strong adherence to key fundamental metrics a compelling factor.
  • Considering ACN's successful evaluation across all nine critical financial health and performance indicators, the stock merits attention for portfolios aiming for exposure to fundamentally sound, large-cap growth entities in the technology services domain.
  • While the current fundamental snapshot is positive, it is prudent for investors to continuously assess ACN's valuation to ensure it remains 'reasonable' as per the strategy's tenets, and to monitor the persistence of these strong financial characteristics.